Market Cap

Bioventus, Inc. Market Capitalization:

$465.8 Million

USD as of July 1, 2025

business Bioventus, Inc. Company Profile

Bioventus, Inc. Main Stock Listing

NASDAQ: BVS

Market Capitalization History of Bioventus, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $162.07 B
Danaher $144.92 B
Siemens Healthineers AG $64.17 B
Lonza Group Ltd $49.67 B
IDEXX Laboratories, Inc. $43.99 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $699.59 B
Johnson & Johnson $374.29 B
AbbVie $336.94 B
Novo Nordisk $309.91 B
UnitedHealth Group $279.90 B

Yearly evolution of Bioventus, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $725.6 M 133.27%
Jan. 1, 2024 $311.1 M 117.35%
Jan. 1, 2023 $143.1 M -82.27%
Jan. 1, 2022 $807.2 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Bioventus, Inc. Categories

United States languages Healthcare languages Diagnostics & Research
United States Healthcare United States Diagnostics & Research

Stocks & Indices

Bioventus, Inc. has the following listings and related stock indices.


Stock: NASDAQ: BVS

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.